Cargando…
Epstein-Barr virus-driven lymphomagenesis in the context of human immunodeficiency virus type 1 infection
Epstein–Barr virus (EBV) is a ubiquitous human γ-herpes virus which establishes a life-long asymptomatic infection in immunocompetent hosts. In human immunodeficiency virus type 1 (HIV-1) infected patients, the impaired immunosurveillance against EBV may favor the development of EBV-related diseases...
Autores principales: | Petrara, Maria R., Freguja, Riccardo, Gianesin, Ketty, Zanchetta, Marisa, De Rossi, Anita |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3799006/ https://www.ncbi.nlm.nih.gov/pubmed/24151490 http://dx.doi.org/10.3389/fmicb.2013.00311 |
Ejemplares similares
-
Host factors and early treatments to restrict paediatric HIV infection and early disease progression
por: Gianesin, Ketty, et al.
Publicado: (2015) -
Relationship between dynamics of Epstein-Barr virus and immune activation in HIV-1 infected subjects in the HAART era
por: Cattelan, AM, et al.
Publicado: (2010) -
Impact of monotherapy on HIV-1 reservoir, immune activation, and co-infection with Epstein-Barr virus
por: Petrara, Maria Raffaella, et al.
Publicado: (2017) -
Human Solid Tumor Xenografts in Immunodeficient Mice Are Vulnerable to Lymphomagenesis Associated with Epstein-Barr Virus
por: Chen, Kui, et al.
Publicado: (2012) -
Polymorphims of innate immunity genes influence disease progression in HIV-1 infected children
por: Freguja, Riccardo, et al.
Publicado: (2012)